Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (CTNG)
This study has been completed.
Sponsor:
University Hospital Inselspital, Berne
Collaborators:
Pfizer
Merck Sharp & Dohme Corp.
Information provided by:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00973466
First received: September 4, 2009
Last updated: January 12, 2011
Last verified: January 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health.
Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.
| Condition |
|---|
|
HIV Infections Neisseria Gonorrhoeae Chlamydia Trachomatis Herpes Simplex |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Prevalence of Asymptomatic and Symptomatic Infection of N. Gonorrheae and C. Trachomatis and Seroprevalence of HSV Typ 2 and Sexual Health Seeking Behaviour in People With HIV Infection in Bern |
Resource links provided by NLM:
Further study details as provided by University Hospital Inselspital, Berne:
Primary Outcome Measures:
- Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 300 |
| Study Start Date: | May 2009 |
| Study Completion Date: | June 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
HIV-infection
All HIV-infected patients attending the Clinic for Infectious Diseases at Berne university hospital, having been sexually active during the past 12 months and having given written informed consent
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
All consecutive HIV-infected patients attending the Clinic for Infectious Diseases at Bern University Hospital will be asked to participate in the study if they were sexually active during the last 12 months
Criteria
Inclusion Criteria:
- HIV-infection
- Attending the Clinic for Infectious Diseases from May 09 to November 09
- Sexually active during the last 12 months
- Written informed consent
Exclusion Criteria:
- None
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00973466
Please refer to this study by its ClinicalTrials.gov identifier: NCT00973466
Locations
| Switzerland | |
| Clinic for Infectious Diseases, Berne University Hospital | |
| Bern, Switzerland, 3010 | |
Sponsors and Collaborators
University Hospital Inselspital, Berne
Pfizer
Merck Sharp & Dohme Corp.
Investigators
| Principal Investigator: | Hansjakob Furrer, MD | University Hospital Berne |
More Information
No publications provided
| Responsible Party: | Hansjakob Furrer, Leitender Arzt, University Hospital Inselspital, Berne |
| ClinicalTrials.gov Identifier: | NCT00973466 History of Changes |
| Other Study ID Numbers: | KEK26/09 |
| Study First Received: | September 4, 2009 |
| Last Updated: | January 12, 2011 |
| Health Authority: | Switzerland: Ethikkommission |
Keywords provided by University Hospital Inselspital, Berne:
|
HIV-infection Neisseria gonorrhea Chlamydia trachomatis Herpes simplex virus prevalence |
Additional relevant MeSH terms:
|
Acquired Immunodeficiency Syndrome Communicable Diseases Gonorrhea HIV Infections Herpes Simplex Infection Bacterial Infections DNA Virus Infections Genital Diseases, Female Genital Diseases, Male Gram-Negative Bacterial Infections Herpesviridae Infections Immune System Diseases |
Immunologic Deficiency Syndromes Lentivirus Infections Neisseriaceae Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Bacterial Sexually Transmitted Diseases, Viral Skin Diseases Skin Diseases, Infectious Skin Diseases, Viral Slow Virus Diseases Virus Diseases |
ClinicalTrials.gov processed this record on February 27, 2015